# A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women

> **NCT00902356** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 69 (actual)

## Conditions studied

- Osteopenia

## Interventions

- **DRUG:** AMG 167
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00902356
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2010-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00902356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00902356, "A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00902356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*